The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants: On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH
Abstract
Summary: Lupus anticoagulants (LAs) are antibodies that interfere with phospholipid dependent coagulation reactions in vitro. This workshop was designed to provide the participants with an experience in identification of LAs, to evaluate different criteria for mixing studies, to assess the performance of recently introduced confirmatory studies and to assess the performance of two potential surrogate LA control plasmas. The results demonstrate that there continues to be significant variation in the sensitivity and responsiveness of APTT reagents to the presence of LAs, confirming the need for more than one screening assay before the presence of a LA can be ruled out. In this workshop, the best distinction between factor deficiency and inhibitors was obtained using a 1:1 mix of normal plasma with patient plasma and the criterion defining correction as shortening of the APTT to within 5 s of the APTT of pooled normal plasma. A 4:1 mix of patient to normal plasma did not work well in distinguishing factor deficiency from inhibitors. The platelet neutralization procedure, DVVconfirm® and StaClot LA® all gave positive results with the LA samples. False positive platelet neutralization procedures were seen with the samples from patients on oral anticoagulants and a factor V inhibitor. False positive StaClot LA results were obtained with high titer factor VIII inhibitors. Both of the potential surrogate plasmas gave variable results with multiple assays; they can not be recommended for routine use at present.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 575
Thrombosis in Patients with the Lupus Anticoagulant
Mueh, J., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 502
Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V., & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.869 · Cited by 422
The Spectrum of Neurologic Disease Associated With Antiphospholipid Antibodies
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)
Nilsson, I. M., Åstedt, B., Hedner, U. K. E., et al. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb04897.x · Cited by 293
Triplett, D. A., Brandt, J. T., Kaczor, D. A., et al. (1983) · American Journal of Clinical Pathology · doi:10.1093/ajcp/79.6.678 · Cited by 276
Self-citationExner, T., Triplett, D. A., Taberner, D. A., & Machin, S. J. (1991) · PubMed · Cited by 243
Self-citation
Cited by
Sorted by citations
Items 201–229 of 229
Rodger, M. A., Paidas, M. J., Tsen, L. C., & Douglas, J. (2010) · doi:10.1002/9781444323016.ch4
Les difficultés diagnostiques des lupus anticoagulants
Massignon, D. (2006) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(06)80193-0
A 43-year-old woman with chest pressure
Mickelson, D. M., Mady, E. N., & Teng, K. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.07006
Diagnostic biologique des anticoagulants circulants de type lupique (lupus anticoagulants)
Arnoux, D., Boutière, B., & Sampol, J. (1997) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(97)80145-x
Laboratory Identification of Lupus Anticoagulants in Thai Patients
Aryurachai, K., & Atichartakarn, V. (2002) · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต)
Hemostatic risk factors for pregnancy-related venous thrombosis
Bergrem, A. (2013) · NORA - Norwegian Open Research Archives
5. Autoimmunological Laboratory Test Abnormality and Its Countermeasures
Kuwana, M. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.2446
New Concept of Clinical Pathology and Treatment of Antiphospholipid Syndrome
Horita, T., & Koike, T. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.1334
Andréoli, L., Pregnolato, F., Fanelli, V., et al. (2008)
The Antiphospholipid Syndrome in Pregnancy: A Review Article
Cacciola, R. R., Cacciola, E. G., & Cacciola, E. (2015)
Salamat, N., Saleem, M. S., & Ahmed, T. (2000) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2000.450
Stubbs, J. R. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30242-7
Antiphospholipid Syndrome in Pregnancy
Begum, N., Ganguly, S., & Islam, F. (2016) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v33i2.28041
Yasuda, S. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2621
The patient at risk from thrombosis and bleeding disorders
Greer, S. N. A. I. (2008) · CRC Press eBooks · doi:10.3109/9780203092200-14
Prevalence of hepatitis C virus i&k&on in patients with antiphospholipid syndrome
Muiioz-Rodriguez, F. J., Tgssies, D., Font, J., et al. (1999)
Laboratory Testing for Antiphospholipid Syndrome
Ioannou, Y., & Krilis, S. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10052-x
Diagnose des Antiphospholipid-Syndrom beim antikoagulierten Patient: Was gibt es zu beachten?
Mohren, M., Daikeler, T. D., Engel, A., Günaydın, İ., & Koetter, I. (2004) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-004-0593-4
Sugimoto, T., Morimoto, K., Hashimoto, H., Kaneda, Y., Ohata, S., & Yasutomo, Y. (2018) · Acta Haematologica Polonica · doi:10.2478/ahp-2018-0007
Monitorización de la coagulación
Ruiz, M. D. P., Vaeza, N. N., & Balanza, J. Á. L. (2004) · Elsevier eBooks · doi:10.1016/b978-84-8174-708-9.50030-x
Rheumatologic and Connective Tissue Disorders in Pregnancy
Leguizamón, G. F., & Reece, E. A. (2007) · Wiley eBooks · doi:10.1002/9780470753293.ch51
The patient at risk from thrombosis and bleeding disorders
Nelson, S. M., & Greer, I. A. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092200.011
Lupus Anticoagulants: Mechanistic and Diagnostic Considerations
Arnout, J., & Vermylen, J. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_23
Antiphospholipid Antibody Syndrome
Zambon, M., Cappelli, D., & Berlot, G. (2012) · Springer eBooks · doi:10.1007/978-88-470-2448-9_13
Delayed Diagnosis in a 61-Year-Old Hispanic Male with Ecchymoses, Soft Tissue Bleeding, and Edema
Abadie, J. M., & Qiao, J. C. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad075
Investigación de la tendencia trombótica
Laffan, M., & Manning, R. A. (2008) · Elsevier eBooks · doi:10.1016/b978-84-8086-229-5.50017-5
Yahia, S. H., Lazarov, H., Niznik, S., Shavit, R., Lubetsky, A., & Agmon-Levin, N. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.03.029
Nouveaux acteurs moléculaires de la dysfonction vasculo-placentaire
Bouvier, S. (2014) · theses.fr (ABES) · doi:10.70675/19197935zffc1z41dczadbcz14dd81f37bf9
Metadata
- Authors
- Brandt, J. T., Barna, L. K., & Triplett, D. A.
- Affiliations
- The Ohio State University (US)
- Ball Memorial Hospital (US)
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1995
- Volume
- 74
- Issue
- 06
- Pages
- 1597-1603
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2417920681
- Cited by
- 228
- References
- 27
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 2 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 12 · 2012: 9
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Keywords
- lupus anticoagulant, mixing studies, activated partial thromboplastin time, factor deficiency, anticoagulants, factor VIII inhibitors, factor V inhibitor, oral anticoagulants
- MeSH terms
- Humans, Laboratories, Partial Thromboplastin Time, Predictive Value of Tests, Prothrombin Time, Reproducibility of Results, Lupus Coagulation Inhibitor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review